Drug trial aims to tame scarring lung disease
Disease control
Terminated
This study tested whether a drug called namilumab could help control chronic pulmonary sarcoidosis, a disease that causes inflammation and scarring in the lungs. About 107 adults with this condition received either the drug or a placebo via injection every four weeks for six mont…
Phase: PHASE2 • Sponsor: Kinevant Sciences GmbH • Aim: Disease control
Last updated Feb 27, 2026 15:18 UTC